We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Evaluates nirsevimab for RSV prevention in term and late-preterm infants, suggesting effective protection.
International audience
No takes yet. Share an insight, caveat, or question.
Muller et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: